Skip to search boxSkip to navigationSkip to main content

Circulating Bile Acids in Liver Failure Activate TGR5 and Induce Monocyte Dysfunction

  • Julia Leonhardt(corresponding author)
    ,
  • Raphael S. Haider
    ,
  • Christoph Sponholz
    ,
  • Silke Leonhardt
    ,
  • Julia Drube
    ,
  • Katrin Spengler
*Corresponding author for this work
Scholary Output:
Contribution to journal
Article
Research
Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

Background & Aims: Retention of bile acids in the blood is a hallmark of liver failure. Recent studies have shown that increased serum bile acid levels correlate with bacterial infection and increased mortality. However, the mechanisms by which circulating bile acids influence patient outcomes still are elusive. Methods: Serum bile acid profiles in 33 critically ill patients with liver failure and their effects on Takeda G-protein–coupled receptor 5 (TGR5), an immunomodulatory receptor that is highly expressed in monocytes, were analyzed using tandem mass spectrometry, novel highly sensitive TGR5 bioluminescence resonance energy transfer using nanoluciferase (NanoBRET, Promega Corp, Madison, WI) technology, and in vitro assays with human monocytes. Results: Twenty-two patients (67%) had serum bile acids that led to distinct TGR5 activation. These TGR5-activating serum bile acids severely compromised monocyte function. The release of proinflammatory cytokines (eg, tumor necrosis factor α or interleukin 6) in response to bacterial challenge was reduced significantly if monocytes were incubated with TGR5-activating serum bile acids from patients with liver failure. By contrast, serum bile acids from healthy volunteers did not influence cytokine release. Monocytes that did not express TGR5 were protected from the bile acid effects. TGR5-activating serum bile acids were a risk factor for a fatal outcome in patients with liver failure, independent of disease severity. Conclusions: Depending on their composition and quantity, serum bile acids in liver failure activate TGR5. TGR5 activation leads to monocyte dysfunction and correlates with mortality, independent of disease activity. This indicates an active role of TGR5 in liver failure. Therefore, TGR5 and bile acid metabolism might be promising targets for the treatment of immune dysfunction in liver failure.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 25-40 (16 pages)

Journal (Volume, Issue Number)

CMGH (Volume 12, Issue 1)

Publication milestones

  • Published - 01/2021

Publication status

Published - 01/2021

Publication IDs

  • Scopus: 85104335544
  • PubMed: 33545429

Publication metrics

Metrics

Fractional count
1
Fractional count
0.06
Fractional count
15
Fractional count
0.94
Fractional count
1
Fractional count
1
Scopus
citations
SciVal
Author count
16
SciVal
Paper percentile
81

PlumX, opens in new tab

Social media
10
Citation count
45
Mentions
1
Captures
35

Funding Details

Funding This study was supported by the Federal Ministry of Education and Research , Germany, FKZ 01EO1502 (J.L.), by the Department of Anesthesiology and Critical Care Medicine , Jena University Hospital , and the Institute for Molecular Cell Biology, Jena University Hospital .
FundersFunding number
BMBF
FKZ 01EO1502
UKJ
-